Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-24 @ 3:50 PM
NCT ID:
NCT00589992
Eligibility Criteria:
Inclusion Criteria:
* patients to be scheduled for atrial fibrillation radio frequency ablation
* paroxysmal, permanent symptomatic atrial fibrillation refractory to conventional treatment
* symptomatic atrial fibrillation that do not want or desire to take medication or undergo cardioversion
* patients on antiarrhythmics that can be discontinued 5 half lifes prior to the procedure except for Amiodarone
Exclusion Criteria:
* patients with recent major hemorrhage (within 6 months)
* patients with a coagulopathy
* patients who are pregnant or breast feeding
* patients with acute congestive heart failure
* patients with hypokalemia or hyperkalemia
* patients with a prolonged QTc \> 440mms
* patients with polymorphic ventricular tachycardia secondary to antiarrhythmic class III and class I
* patients with left ventricular dysfunction \< 40%
* patients with a history of recent MI (\< 1 month)
* patients with a history of an angioplasty of \< 1 month
* patients with a history of coronary artery bypass grafting surgery of \< 3 months.
* patients with a history of chronic renal failure or a creatinine clearance of \< 30ml/m
* patients with a history of stroke of \< 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00589992
Study Brief:
Protocol Section:
NCT00589992